Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
Saved in:
| Title: | Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia. |
|---|---|
| Authors: | Dovey OM; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Cooper JL; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Mupo A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Grove CS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia.; PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia., Lynn C; Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom., Conte N; Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Andrews RM; Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom., Pacharne S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Tzelepis K; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Vijayabaskar MS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Green P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Rad R; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany., Arends M; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Wright P; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and., Yusa K; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Bradley A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain., Vassiliou GS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and. |
| Source: | Blood [Blood] 2017 Oct 26; Vol. 130 (17), pp. 1911-1922. Date of Electronic Publication: 2017 Aug 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
